[1]
Mansour, M.F. et al. 2024. Silymarin-loaded chitosan nanoparticles alleviate dyslipidemia, oxidative stress, metabolic disturbance and histopathological injury associated with high fat diet-induced non-alcoholic fatty liver disease in rats. Journal of Advanced Veterinary Research. 14, 3 (Mar. 2024), 439–444.